Immunogenetics: A Molecular and Clinical Overview, Vol. 3: Immune Cells and Immunotherapeutics in Recurrent Miscarriage
Editat de Shafat Ali, Muneeb U Rehman, Shahnaz Taing, Azher Arafahen Limba Engleză Paperback – 2 iun 2025
- Contains global information about research on immunogenetics of recurrent pregnancy loss
- Assists clinicians and medical practitioners by presenting the most recent research information, ideas, thoughts of scientists and researchers, and trends in this research area
- Provides the prerequisite requirements for any researcher who wants to work on immunogenetics and its applications to recurrent pregnancy loss
Preț: 814.59 lei
Preț vechi: 857.46 lei
-5% Nou
Puncte Express: 1222
Preț estimativ în valută:
155.95€ • 162.10$ • 129.30£
155.95€ • 162.10$ • 129.30£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443136177
ISBN-10: 0443136173
Pagini: 350
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0443136173
Pagini: 350
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Cuprins
1. Role of CD4+ T helper cells (Th1, Th2 and Th17 cells) in Recurrent pregnancy loss
2. Role of Nature Killer and Innate lymphoid cells in Recurrent pregnancy loss
3. Role of T Regulatory in Recurrent pregnancy loss
4. Role of CD8+ Cytotoxic T cells in Recurrent pregnancy loss
5. Role of B cells, macrophages and dendritic cells in Recurrent pregnancy loss
6. Clinical outcome of Low molecular weight heparin and aspirin therapy in Recurrent pregnancy loss patients
7. Clinical outcome of Intravenous immunoglobulin (IVIg) therapy in Recurrent pregnancy loss patients
8. Vitamin D3 therapy and clinical outcome in Recurrent pregnancy loss patients
9. Efficacy of Intralipid infusion therapy in the treatment of Recurrent pregnancy loss patients
10. Therapeutic potential of Cyclosporine A in Recurrent pregnancy loss
11. Progesterone therapy and clinical outcome in Recurrent pregnancy loss patients
12. Granulocyte-Colony Stimulating Factor (G-CSF) therapy in Recurrent pregnancy loss patients
13. Lymphocyte immunotherapy (LIT) and clinical outcome in Recurrent pregnancy loss patients
14. TNFα inhibition and treatment of Recurrent pregnancy loss
15. Genetic counselling and clinical pregnancy outcome
16. Importance of evidence-based medical treatments for Recurrent pregnancy loss
17. Evidence-based new developments in reproductive immunogenetics and future perspectives
2. Role of Nature Killer and Innate lymphoid cells in Recurrent pregnancy loss
3. Role of T Regulatory in Recurrent pregnancy loss
4. Role of CD8+ Cytotoxic T cells in Recurrent pregnancy loss
5. Role of B cells, macrophages and dendritic cells in Recurrent pregnancy loss
6. Clinical outcome of Low molecular weight heparin and aspirin therapy in Recurrent pregnancy loss patients
7. Clinical outcome of Intravenous immunoglobulin (IVIg) therapy in Recurrent pregnancy loss patients
8. Vitamin D3 therapy and clinical outcome in Recurrent pregnancy loss patients
9. Efficacy of Intralipid infusion therapy in the treatment of Recurrent pregnancy loss patients
10. Therapeutic potential of Cyclosporine A in Recurrent pregnancy loss
11. Progesterone therapy and clinical outcome in Recurrent pregnancy loss patients
12. Granulocyte-Colony Stimulating Factor (G-CSF) therapy in Recurrent pregnancy loss patients
13. Lymphocyte immunotherapy (LIT) and clinical outcome in Recurrent pregnancy loss patients
14. TNFα inhibition and treatment of Recurrent pregnancy loss
15. Genetic counselling and clinical pregnancy outcome
16. Importance of evidence-based medical treatments for Recurrent pregnancy loss
17. Evidence-based new developments in reproductive immunogenetics and future perspectives